have investigated the influence of cellular sialylation on the GnT-III-mediated regulation of cancer cell metastatic potential. The authors demonstrated that GnT-III (GlcNAc-bisecting glycosyltransferase) overexpression results in a significant reduction of ␣2,3sialylation, with no major alteration of ␣2,6-sialylation (1). Interestingly, a reciprocal correlation between terminal ␣2,3-sialylation and bisected N-glycans has also been recently reported (2). Glycomic analysis of cancer cells overexpressing the ␣2,3-sialyltransferase ST3GAL4 showed that increased terminal ␣2,3-sialylation is accompanied by a substantial loss of bisected N-glycans (2).
Increased ␣2,3-sialylation is associated with malignancy and patients' poorer prognosis, whereas bisected N-glycans suppress metastization (4). Moreover, N-glycan branching and sialylation patterns determine galectin lattice dynamics with critical impact on tumor cell signaling and definition of aggressiveness features (5). Therefore, deciphering the mechanisms underlying reciprocal regulation of terminal sialylation and bisecting N-glycans is fundamental for our understanding of tumor cell biology. 
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